These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11550502)

  • 41. Evaluation of the therapeutic effect of pefloxacin in comparison with ampicillin and gentamicin in cirrhotic patients with spontaneous bacterial peritonitis.
    Rastegar LA; Umrani G; Dehbashi N; Malec F
    Hepatogastroenterology; 1998; 45(21):783-5. PubMed ID: 9684134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Broad-spectrum fluoroquinolones. Passed safety tests up to now].
    MMW Fortschr Med; 2001 Feb; 143(6):59. PubMed ID: 11247374
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pefloxacin in the treatment of septicemia, purulent meningitis and salmonellosis].
    Dordević D; Kaplan M; Cengić D; Vranić B; Dimitrijević K
    Med Arh; 1989; 43(4-6):207-10. PubMed ID: 2640275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Tendinitis of the Achilles tendon caused by pefloxacin and other fluoroquinolone derivatives].
    Dekens-Konter JA; Knol A; Olsson S; Meyboom RH; de Koning GH
    Ned Tijdschr Geneeskd; 1994 Mar; 138(10):528-31. PubMed ID: 8139714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antimicrobial activity of pefloxacin in comparison with other quinolones].
    Darenkov AF; Kotliarova GA; Kondrat'eva EM
    Antibiot Khimioter; 1991 Nov; 36(11):24-6. PubMed ID: 1793290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pefloxacin-induced arthropathy in an adolescent with brain abscess.
    Chang H; Chung MH; Kim JH; Kim JH
    Scand J Infect Dis; 1996; 28(6):641-3. PubMed ID: 9060073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of fluoroquinolones in rheumatology].
    Belov BS; Shubin SV; Nasonova VA; Soldatova SI; Tarasova GM; Urumova MM; Ushakova MA; Anan'eva LP
    Vestn Ross Akad Med Nauk; 1996; (12):12-5. PubMed ID: 9102072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does the use of fluoroquinolones for the empiric treatment of pneumonia delay initiation of treatment of tuberculosis?
    Abiad H
    Clin Infect Dis; 2002 Dec; 35(12):1572; author reply 1572-3. PubMed ID: 12471582
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy and safety of levofloxacin in patients with bacterial pneumonia evaluated according to the new "Clinical Evaluation Methods for New Antimicrobial Agents to Treat Respiratory Infections (Second Version)".
    Mukae H; Kawanami T; Yatera K; Yanagihara K; Yamamoto Y; Kakeya H; Tokimatsu I; Kadota J; Kohno S
    J Infect Chemother; 2014 Jul; 20(7):417-22. PubMed ID: 24787737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Symposium "Abactal (pefloxacin)--new possibilities in antibacterial therapy"].
    Iakovlev VP
    Antibiot Khimioter; 1991 Nov; 36(11):52-3. PubMed ID: 1686542
    [No Abstract]   [Full Text] [Related]  

  • 51. [Infection prophylaxis in open leg fractures. Comparison of a dose of pefloxacin and 5 days of cefazolin-oxacillin. A randomized study of 616 cases].
    Gagey O; Doyon F; Dellamonica P; Carsenti-Etesse H; Desplaces N; Tancrède C; Evrard J
    Rev Chir Orthop Reparatrice Appar Mot; 1999 Jul; 85(4):328-36. PubMed ID: 10457551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical efficacy of the new quinolones in lower respiratory infections.
    Davies BI; Maesen FP
    Chemioterapia; 1987 Jun; 6(2 Suppl):447-8. PubMed ID: 3509469
    [No Abstract]   [Full Text] [Related]  

  • 53. Protective role of the pefloxacin-IFN-gamma association in Leishmania major-infected mice.
    Zucca M; Millesimo M; Giovarelli M; Diverio D; Musso T; Savoia D
    New Microbiol; 1996 Jan; 19(1):39-46. PubMed ID: 8673851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Ciprofloxacin: a warning for clinicians".
    Breck RW
    Conn Med; 2002 Oct; 66(10):635. PubMed ID: 12448217
    [No Abstract]   [Full Text] [Related]  

  • 55. Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP; Baur C
    Eur J Respir Dis Suppl; 1986; 146():585-90. PubMed ID: 3465584
    [No Abstract]   [Full Text] [Related]  

  • 56. [Neurologic side effects of fluoroquinolones. Apropos of 9 cases concerning pefloxacin].
    Andrejak M; Schmit JL; Tondriaux A; Hary L; Debailleux S; Moore N
    Therapie; 1992; 47(5):415-8. PubMed ID: 1299981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy and tolerance of pefloxacin in the treatment of complicated urinary tract infections in Tunisia].
    Ayed M
    Tunis Med; 1992 Nov; 70(11):541-6. PubMed ID: 1295170
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Antibiot Khimioter; 1996 Jan; 41(1):19-21. PubMed ID: 8762820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The antibacterial therapy of community-acquired pneumonia].
    Khveshchuk PF; Rakov AL; Sinopal'nikov AI; Rudakova AV
    Voen Med Zh; 1999 Jan; 320(1):25-36. PubMed ID: 10200622
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical effects and bronchoalveolar transfer of levofloxacin in patients with community-acquired pneumonia.
    Lin Y; Su W; Xu Z; Bai Y
    Chin Med J (Engl); 2001 Feb; 114(2):212-3. PubMed ID: 11780213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.